Who are Jinshuibao Capsule's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Danning Tablet.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/jinshuibao-capsule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Jinshuibao Capsule — Competitive Intelligence Brief

Jinshuibao Capsule (Jinshuibao Capsule) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese Medicine (TCM) herbal formulation. Area: Nephrology.

marketed Traditional Chinese Medicine (TCM) herbal formulation Nephrology Small molecule Live · refreshed every 30 min

Target snapshot

Jinshuibao Capsule (Jinshuibao Capsule) — Second Xiangya Hospital of Central South University. Jinshuibao Capsule is a traditional Chinese medicine formulation that enhances renal blood perfusion and protects kidney function through multi-component herbal synergy.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Jinshuibao Capsule TARGET	Jinshuibao Capsule	Second Xiangya Hospital of Central South University	marketed	Traditional Chinese Medicine (TCM) herbal formulation
Danning Tablet	Danning Tablet	Eastern Hepatobiliary Surgery Hospital	marketed	Traditional Chinese Medicine (TCM) herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese Medicine (TCM) herbal formulation class)

Eastern Hepatobiliary Surgery Hospital · 1 drug in this class
Second Xiangya Hospital of Central South University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Jinshuibao Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/jinshuibao-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab